Article
8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer.
Urology - 1 May 2000
Macoska J A, Trybus T M, Wojno K J
Abstract excerpt
OBJECTIVES: A critical issue in the management of prostate cancer is the ability to distinguish patients at risk of disease recurrence. The aim of this study was to determine whether specific physical alterations of chromosome 8 may be associated with disease recurrence and poor outcome using postoperative prostate-specific antigen (PSA) values as surrogate end points. METHODS: To test this hypothesis, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
